| Phytoestrogen, NO Donors, N-acetyl Cysteine Add Therapy to Clomiphene Citrate to Improve Pregnancy Rate in PCO Patients (NCT02493933) | Kasr El Aini Hospital | 2015-07-01 |
| Oxytocin and the Processing of Social Stress-Associated Chemosignals (NCT03265899) | University Hospital, Bonn | 2015-07-01 |
| Study of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII Deficiency (NCT02470871) | CSL Behring | 2015-07-01 |
| Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder (NCT03143543) | Virginia Commonwealth University | 2015-07-01 |
| Systemic Bioactivity of Inhaled Nebulized RNS60 (NCT02490865) | Revalesio Corporation | 2015-07-01 |
| Effect of AKB-6548 on the Pharmacokinetics of Celecoxib (NCT02502500) | Akebia Therapeutics | 2015-07-01 |
| Telerehabilitation Upper Extremity for Neurological Disorders (NCT02764372) | Fondazione Don Carlo Gnocchi ETS | 2015-07-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males (NCT02484729) | AstraZeneca | 2015-07-01 |
| Reactivating NK Cells in Treating Refractory Head and Neck Cancer (NCT02507154) | National University Hospital, Singapore | 2015-07-01 |
| TIL Therapy for Metastatic Ovarian Cancer (NCT02482090) | Inge Marie Svane | 2015-07-01 |
| An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects (NCT02475746) | Pfizer | 2015-07-01 |
| Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants (NCT02256631) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-06-30 |
| Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation (NCT02511041) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-06-30 |
| Treatment of Familiar Lymphohistiocytosis (NCT02472054) | Assistance Publique - Hôpitaux de Paris | 2015-06-29 |
| A Phase 1 Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers (NCT02470286) | Samjin Pharmaceutical Co., Ltd. | 2015-06-29 |
| A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors (NCT02350673) | Hoffmann-La Roche | 2015-06-29 |
| A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years (NCT04421105) | Eleusis Therapeutics | 2015-06-29 |
| Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older (NCT02494882) | Memorial Sloan Kettering Cancer Center | 2015-06-29 |
| Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... (NCT02484404) | National Cancer Institute (NCI) | 2015-06-29 |
| Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143 (NCT02521389) | MEI Pharma, Inc. | 2015-06-29 |
| Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies (NCT02419495) | M.D. Anderson Cancer Center | 2015-06-26 |
| A Study Evaluating the Safety of Tocilizumab in Addition to Standard of Care Premedication Given Before Obinutuzumab + Chlorambucil in Participants With Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Comorbidities (NCT02336048) | Hoffmann-La Roche | 2015-06-26 |
| Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) (NCT02499770) | G1 Therapeutics, Inc. | 2015-06-26 |
| Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis (NCT02693366) | Universidade Federal do Rio de Janeiro | 2015-06-25 |
| Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia (NCT02446964) | City of Hope Medical Center | 2015-06-25 |
| In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma (NCT02489266) | National Cancer Institute (NCI) | 2015-06-24 |
| Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease (NCT02434718) | Biogen | 2015-06-24 |
| Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours (NCT02343718) | Canadian Cancer Trials Group | 2015-06-24 |
| Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users (NCT04110535) | Paion UK Ltd. | 2015-06-23 |
| The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824) (NCT02473367) | Merck Sharp & Dohme LLC | 2015-06-23 |
| A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004) (NCT02461563) | Merck Sharp & Dohme LLC | 2015-06-23 |
| A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers (NCT02354950) | ViiV Healthcare | 2015-06-22 |
| Bioequivalence Evaluation of a New and Current Tablet of ASP015K (NCT02531191) | Astellas Pharma Inc | 2015-06-21 |
| Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors (NCT02444546) | Mayo Clinic | 2015-06-21 |
| Study of BMS-986158 in Subjects With Select Advanced Cancers (NCT02419417) | Bristol-Myers Squibb | 2015-06-19 |
| A Study of BMS-986148 in Patients With Select Advanced Solid Tumors (NCT02341625) | Bristol-Myers Squibb | 2015-06-19 |
| Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis (NCT02397382) | Janssen Research & Development, LLC | 2015-06-18 |
| Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE) (NCT02338999) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2015-06-18 |
| Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma (NCT02446236) | Hackensack Meridian Health | 2015-06-18 |
| A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy (NCT02469688) | Astellas Pharma Inc | 2015-06-18 |
| A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML (NCT02403310) | H. Lee Moffitt Cancer Center and Research Institute | 2015-06-18 |
| Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy (NCT02348320) | Washington University School of Medicine | 2015-06-17 |
| Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. (NCT02460224) | Novartis Pharmaceuticals | 2015-06-17 |
| Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies (NCT02457598) | Gilead Sciences | 2015-06-16 |
| Food Effect Study of Anaprazole in Healthy Chinese Subjects (NCT04463173) | Sihuan Pharmaceutical Holdings Group Ltd. | 2015-06-16 |
| A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT02457793) | Genentech, Inc. | 2015-06-16 |
| Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia (NCT02416908) | Washington University School of Medicine | 2015-06-16 |
| Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation (NCT02426684) | Cedars-Sinai Medical Center | 2015-06-16 |
| A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies (NCT02454270) | Janssen Research & Development, LLC | 2015-06-15 |
| Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors (NCT02458339) | The University of Texas Health Science Center, Houston | 2015-06-15 |
| Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel (NCT02439346) | Bayer | 2015-06-15 |
| INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function (NCT02474537) | Novartis Pharmaceuticals | 2015-06-12 |
| ART-2 Pilot - Driving Pressure Limited Ventilation for Patients With ARDS (NCT02365038) | Hospital do Coracao | 2015-06-12 |
| Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial (NCT02305134) | Chiba University | 2015-06-11 |
| Sympatholysis in Chronic Kidney Disease (NCT02411773) | Emory University | 2015-06-11 |
| A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder (NCT02476058) | Janssen-Cilag International NV | 2015-06-11 |
| Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet (NCT03074058) | Bayer | 2015-06-10 |
| Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B (NCT02396342) | CSL Behring | 2015-06-10 |
| The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour. (NCT02430311) | AstraZeneca | 2015-06-10 |
| Indocyanine Green for Central Nervous System Tumors (NCT02710240) | Abramson Cancer Center at Penn Medicine | 2015-06-10 |
| Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma (NCT02303392) | Jennifer Woyach | 2015-06-09 |
| Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole (NCT02476955) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2015-06-09 |
| Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects (NCT02472236) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2015-06-08 |
| fPAM for the in Vivo Depth Measurement of Pigmented Lesions and Melanoma Depth (NCT02613325) | Washington University School of Medicine | 2015-06-08 |
| Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma (NCT02364206) | Centre Jean Perrin | 2015-06-08 |
| Pharmacokinetic Non-interaction Study With a Fixed-dose Combination Tablet With Tramadol and Diclofenac (NCT03766984) | Grünenthal GmbH | 2015-06-07 |
| AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients (NCT02440568) | University of Illinois at Chicago | 2015-06-05 |
| Study to Assess the Safety and Impact on Humoral Sensitization of SANGUINATE in Patients With End Stage Renal Disease (NCT02437422) | Prolong Pharmaceuticals | 2015-06-05 |
| Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis With Progressive or Relapsed Disease (NCT02436135) | Gilead Sciences | 2015-06-05 |
| ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT02325557) | Advaxis, Inc. | 2015-06-04 |
| A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC) (NCT02411591) | Eli Lilly and Company | 2015-06-04 |
| Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC (NCT02382406) | Nisha Mohindra, MD | 2015-06-04 |
| Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (NCT02412306) | Amgen | 2015-06-04 |
| Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT) (NCT01906385) | Plus Therapeutics | 2015-06-03 |
| Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma (NCT02359565) | National Cancer Institute (NCI) | 2015-06-03 |
| Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NCT02393209) | Millennium Pharmaceuticals, Inc. | 2015-06-03 |
| HPPH Photodynamic Therapy for Patients With Esophageal Cancer (NCT03757754) | Zhejiang Hisun Pharmaceutical Co. Ltd. | 2015-06-03 |
| Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children (NCT02335905) | Baylor College of Medicine | 2015-06-03 |
| Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors (NCT02407990) | BeiGene | 2015-06-02 |
| Ibuprofen Suspension Bioequivalence Study (NCT02503085) | Reckitt Benckiser Healthcare (UK) Limited | 2015-06-02 |
| Phase I Study of the Combination of MLN9708 and Fulvestrant (NCT02384746) | Dartmouth-Hitchcock Medical Center | 2015-06-02 |
| "Novo C Plus" Vitamin C Containing Dietary Supplement Bioavailability in Healthy Subjects (NCT02606773) | Semmelweis University | 2015-06-01 |
| Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle (NCT02438423) | Mark Prausnitz | 2015-06-01 |
| Pharmacokinetics of Two Intravaginal Rings (IVRs) Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048 (NCT02419456) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-06-01 |
| Single-Dose Administration Trial of TLC599 in Osteoarthritis of the Knee (NCT02803307) | Taiwan Liposome Company | 2015-06-01 |
| Look at Food and Lose Your Fear - Evaluation of a Computerized Attention Training (CAT) for Anorexia Nervosa Patients (NCT02484599) | King's College London | 2015-06-01 |
| Study to Assess the Relative Potency of Multiple Oral Doses of LUM001 and SHP626 in Overweight and Obese Adults as Assessed by Fecal Bile Acid Excretion (NCT02475317) | Mirum Pharmaceuticals, Inc. | 2015-06-01 |
| A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer (NCT02105350) | University Health Network, Toronto | 2015-06-01 |
| Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme (NCT02331498) | Centre Antoine Lacassagne | 2015-06-01 |
| Evaluation of Biosynthetic Constructs to Replace Donor Corneas (NCT02374723) | Region Östergötland | 2015-06-01 |
| Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients (NCT02855112) | Tehran University of Medical Sciences | 2015-06-01 |
| A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects (NCT02500667) | Nivalis Therapeutics, Inc. | 2015-06-01 |
| Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People (NCT02191098) | University of Minnesota | 2015-06-01 |
| Acute Effects of Spices on Pathways Associated With Glucose Homeostasis and Inflammation on PBMCs of Healthy Subjects (NCT02479334) | Lund University | 2015-06-01 |
| Phase I Nicotinic Agonist Treatment Trial for Autism (NCT02111551) | University of Colorado, Denver | 2015-06-01 |
| A Study of [14c]-Samidorphan (Also Known as ALKS 33) in Healthy, Male Volunteers (NCT02504463) | Alkermes, Inc. | 2015-06-01 |
| The Effect of Metformin on Composition of Human Gut Bacteria (NCT02546050) | Oluf Borbye Pedersen | 2015-06-01 |
| Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder (NCT02375880) | Leap Therapeutics, Inc. | 2015-06-01 |
| Effectiveness and Safety of Autologous ADRC for Treatment of Anterior Cruciate Ligament Partial Rupture (NCT02469792) | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 2015-06-01 |
| Sodium Nitrate for Muscular Dystrophy (NCT02434627) | Cedars-Sinai Medical Center | 2015-06-01 |